Articles prepublished December 21, 2011

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH10-03-0204
Issue:2010: 104/5 (Nov) pp. 863-1082
Pages:1078-1079

Issue
Article

An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

M. M. Samama (1, 2), J. Amiral (3), C. Guinet (2), E. Perzborn (4), F. Depasse (2)

(1) Hôtel-Dieu University Hospital, Paris, France; (2) Biomnis Laboratories R&D, Ivry sur Seine, France; (3) HyphenBiomed, Neuville sur Oise, France; (4) Bayer HealthCare AG, Wuppertal, Germany

DOI

http://dx.doi.org/10.1160/TH10-03-0204
[PDF] [Pay per view] [Add to basket]

Articles

You've 1004 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

TH 107.3

Are optimists less likely to suffer from VTE? Read the original article by Enga et al....